These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Topical use of antifibrinolytic agent to reduce postoperative bleeding after coronary artery bypass surgery. Breda JR; Gurian DB; Breda AS; Meneghine A; Freitas AC; Matos LL; Abreu LC; Pires AC Rev Bras Cir Cardiovasc; 2009; 24(3):341-5. PubMed ID: 20011881 [TBL] [Abstract][Full Text] [Related]
4. A randomized trial of the topical effect of antifibrinolytic epsilon aminocaproic Acid on coronary artery bypass surgery without cardiopulmonary bypass. Gurian DB; Meneghini A; Abreu LC; Murad N; Matos LL; Pires AC; Valenti VE; Breda JR Clin Appl Thromb Hemost; 2014 Sep; 20(6):615-20. PubMed ID: 23434921 [TBL] [Abstract][Full Text] [Related]
5. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety. Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855 [TBL] [Abstract][Full Text] [Related]
6. Postoperative bleeding after coronary revascularization. Comparison between tranexamic acid and epsilon-aminocaproic acid. Maineri P; Covaia G; Realini M; Caccia G; Ucussich E; Luraschi M; Crosta A; Foresti B; Chiaranda M Minerva Cardioangiol; 2000 Jun; 48(6):155-60. PubMed ID: 11048468 [TBL] [Abstract][Full Text] [Related]
7. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364 [TBL] [Abstract][Full Text] [Related]
8. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584 [TBL] [Abstract][Full Text] [Related]
10. Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid. Karski JM; Teasdale SJ; Norman PH; Carroll JA; Weisel RD; Glynn MF J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):431-5. PubMed ID: 8104526 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of epsilon-aminocaproic acid in patients undergoing aortocoronary bypass surgery. Butterworth J; James RL; Lin Y; Prielipp RC; Hudspeth AS Anesthesiology; 1999 Jun; 90(6):1624-35. PubMed ID: 10360861 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of epsilon-aminocaproic acid in children undergoing cardiac surgery. Williams GD; Bratton SL; Riley EC; Ramamoorthy C J Cardiothorac Vasc Anesth; 1999 Jun; 13(3):304-8. PubMed ID: 10392682 [TBL] [Abstract][Full Text] [Related]
13. Association of Epsilon-Aminocaproic Acid With Blood Loss and Risk of Transfusion After Periacetabular Osteotomy: A Retrospective Cohort Study. McLawhorn AS; Levack AE; Fields KG; Sheha ED; DelPizzo KR; Sink EL J Arthroplasty; 2016 Mar; 31(3):626-32. PubMed ID: 26626774 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. Kikura M; Levy JH; Tanaka KA; Ramsay JG J Am Coll Surg; 2006 Feb; 202(2):216-22; quiz A44-5. PubMed ID: 16427545 [TBL] [Abstract][Full Text] [Related]
15. Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study. Daily PO; Lamphere JA; Dembitsky WP; Adamson RM; Dans NF J Thorac Cardiovasc Surg; 1994 Jul; 108(1):99-106; discussion 106-8. PubMed ID: 8028387 [TBL] [Abstract][Full Text] [Related]
16. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs. Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360 [TBL] [Abstract][Full Text] [Related]
17. Intraoperative Use of Epsilon Amino Caproic Acid and Tranexamic Acid in Surgeries Performed Under Cardiopulmonary Bypass: a Comparative Study To Assess Their Impact On Reopening Due To Postoperative Bleeding. Choudhuri P; Biswas BK Ethiop J Health Sci; 2015 Jul; 25(3):273-8. PubMed ID: 26633931 [TBL] [Abstract][Full Text] [Related]
18. The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting. Troianos CA; Sypula RW; Lucas DM; D'Amico F; Mathie TB; Desai M; Pasqual RT; Pellegrini RV; Newfeld ML Anesthesiology; 1999 Aug; 91(2):430-5. PubMed ID: 10443606 [TBL] [Abstract][Full Text] [Related]
19. The effect of coagulation protection with combination of epsilon aminocaproic acid and plasma saver in open-heart surgery. Liu YC; Tsai TP Acta Anaesthesiol Sin; 1998 Sep; 36(3):149-54. PubMed ID: 9874863 [TBL] [Abstract][Full Text] [Related]
20. Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost. Ray MJ; O'Brien MF Ann Thorac Surg; 2001 Mar; 71(3):838-43. PubMed ID: 11269462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]